Updated on 01/14/2022

COVID-19: Pfizer Booster Doses for Ages 12+ & Immunocompromised Ages 5–11

On January 3, the FDA amended the Pfizer-BioNTech COVID-19 Vaccine Emergency Use Authorization (PDF) to authorize the use of a single booster dose for:

  • All patients 12 years and older
  • Immunocompromised patients 5–11 years old

Get the most current list of billing codes, payment allowances, and effective dates.

Article published by CMS on January 13, 2021
CLICK HERE to read original post